Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis

Nuclear Medicine and Biology

Volumn 38, Issue 3, 2011, Pages 381-392

  Bauwens, Matthias ^a   De Saint Hubert, Marijke ^a   Devos, Ellen ^a   Deckers, Niko ^b   Reutelingsperger, Chris ^b   Mortelmans, Luc ^a   Himmelreich, Uwe ^a   Mottaghy, Felix M ^c   Verbruggen, Alfons ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

68Ga ; Annexin a5; Apoptosis; PET; Therapy evaluation

Indexed keywords

CYCLOPHOSPHAMIDE; FAS ANTIBODY; GALLIUM DOTAMALEIMIDE CYSTEINE 165 ANNEXIN A5 GA 68; GALLIUM DOTAMALEIMIDE CYSTEINE 2 ANNEXIN A5 GA 68; TRACER; UNCLASSIFIED DRUG; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10-TETRAAZACYCLODODECANE- 1,4,7,10-TETRAACETIC ACID; DIAGNOSTIC AGENT; FAS ANTIGEN; GALLIUM; LIPOCORTIN 5; MALEIMIDE; MALEIMIDE DERIVATIVE; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE; SINGLE HETEROCYCLIC RINGS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOBLAST; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CONTROLLED STUDY; DAUDI CELL; DRUG BINDING; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RETENTION; DRUG UPTAKE; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY CLEARANCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; URINE RETENTION; ANIMAL; BINDING SITE; CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; METHODOLOGY; RADIATION EXPOSURE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANNEXIN A5; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BINDING SITES; BIOLOGICAL TRANSPORT; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; ISOTOPE LABELING; JURKAT CELLS; MALEIMIDES; MICE; PHOSPHATIDYLSERINES; POSITRON-EMISSION TOMOGRAPHY; SUBSTRATE SPECIFICITY;

EID: 79954419481     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.09.008     Document Type: Article

References (32)

1. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
2. Joseph B., Lewensohn R., Zhivotovsky B. Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann N Y Acad Sci 2000, 926:204-216.
3. Fromigue O., Lagneaux L., Body J.J. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 2000, 15:2211-2221.
4. Amezcua C.A., Lu J.J., Felix J.C., Stanczyk F.Z., Zheng W. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol 2000, 79:169-176.
5. Neves A.A., Brindle K.M. Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 2006, 1766:242-261.
6. De Saint-Hubert M., Prinsen K., Mortelmans L., Verbruggen A., Mottaghy F.M. Molecular imaging of cell death. Methods 2009, 48:178-187.
7. Hofstra L., Liem I.H., Dumont E.A., Boersma H.H., van Heerde W.L., Doevendans P.A., et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000, 356:209-212.
8. Belhocine T., Steinmetz N., Hustinx R., Bartsch P., Jerusalem G., Seidel L., et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 2002, 8:2766-2774.
9. Belhocine T., Steinmetz N., Li C., Green A., Blankenberg F.G. The imaging of apoptosis with the radiolabeled annexin V: optimal timing for clinical feasibility. Technol Cancer Res Treat 2004, 3:23-32.
10. Tait J.F., Smith C., Blankenberg F.G. Structural requirements for in vivo detection of cell death with 99mTc-annexin V. J Nucl Med 2005, 46:807-815.
11. Tait J.F., Smith C., Levashova Z., Patel B., Blankenberg F.G., Vanderheyden J.L. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. J Nucl Med 2006, 47:1546-1553.
12. Li X., Link J.M., Stekhova S., Yagle K.J., Smith C., Krohn K.A., et al. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug Chem 2008, 19:1684-1688.
13. Grierson J.R., Yagle K.J., Eary J.F., Tait J.F., Gibson D.F., Lewellen B., et al. Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 2004, 15:373-379.
14. Yagle K.J., Eary J.F., Tait J.F., Grierson J.R., Link J.M., Lewellen B., et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 2005, 46:658-666.
15. Smith-Jones P.M., Afroze A., Zanzonico P., Tait J., Larson S.M., Strauss H.W. 68Ga labelling of annexin-V: comparison to 99mTc-annexin-V and 67Ga-annexin. J Nucl Med 2003, 44:49-50. [abstract].
16. De Saint-Hubert M., Mottaghy F.M., Vunckx K., Nuyts J., Fonge H., Prinsen K., et al. Site-specific labeling of 'second generation' annexin V with 99mTc(CO)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem 2010, 18:1356-1363.
17. Prinzen L., Miserus R.J., Dirksen A., Hackeng T.M., Deckers N., Bitsch N.J., et al. Optical and magnetic resonance imaging of cell death and platelet activation using annexin a5-functionalized quantum dots. Nano Lett 2007, 7:93-100.
18. van Tilborg G.A., Mulder W.J., Deckers N., Storm G., Reutelingsperger C.P., Strijkers G.J., et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem 2006, 17:741-749.
19. Schellenberger E., Schnorr J., Reutelingsperger C., Ungethüm L., Meyer W., Taupitz M., et al. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 2008, 4:225-230.
20. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
21. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364:806-809.
22. Hampton M.B., Vanags D.M., Porn-Ares M.I., Orrenius S. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett 1996, 399:277-282.
23. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301:527-530.
24. Ghetie M.A., Richardson J., Tucker T., Jones D., Uhr J.W., Vitetta E.S. Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int J Cancer 1990, 45:481-485.
25. Spaepen K., Stroobants S., Dupont P., Bormans G., Balzarini J., Verhoef G., et al. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur J Nucl Med Mol Imaging 2003, 30:682-688.
26. Takei T., Kuge Y., Zhao S., Sato M., Strauss H.W., Blankenberg F.G., et al. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model. J Nucl Med 2004, 45:2083-2087.
27. Mirkovic N., Meyn R.E., Hunter N.R., Milas L. Radiation-induced apoptosis in a murine lymphoma in vivo. Radiother Oncol 1994, 33:11-16.
28. Wolters S.L., Corsten M.F., Reutelingsperger C.P., Narula J., Hofstra L. Cardiovascular molecular imaging of apoptosis. Eur J Nucl Med Mol Imaging 2007, 34(Suppl 1):S86-S98.
29. Mandl S.J., Mari C., Edinger M., Negrin R.S., Tait J.F., Contag C.H., et al. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 2004, 3:1-8.
30. Ke S., Wen X., Wu Q.P., Wallace S., Charnsangavej C., Stachowiak A.M., et al. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med 2004, 45:108-115.
31. Wen X., Wu Q.P., Ke S., Wallace S., Charnsangavej C., Huang P., et al. Improved radiolabeling of PEGylated protein: PEGylated annexin V for noninvasive imaging of tumor apoptosis. Cancer Biother Radiopharm 2003, 18:819-827.
32. Lorberboym M., Blankenberg F.G., Sadeh M., Lampl Y. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res 2006, 1103:13-19.